Discover 1,294 paid clinical trials in Chandler, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Chandler AZ, Gilbert AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase 3, Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
for
Metastatic Castration-Resistant Prostate Cancer
Location: Chandler AZ, Gilbert AZ, Mesa AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT06629779
Phase 3, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Chandler AZ, Gilbert AZ, Las Vegas NV, Redlands CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Chandler AZ, Las Vegas NV, La Jolla CA, Oceanside CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase 3, Recruiting
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
for
Advanced Melanoma
Location: Chandler AZ, Colorado Springs CO, Santa Rosa CA,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT06697301
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Location: Chandler AZ, La Jolla CA, Newport Beach CA,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 18+
Code: NCT05059444
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Chandler AZ, Gilbert AZ, Los Alamitos CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Chandler AZ, Gilbert AZ, Mesa AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase 3, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Chandler AZ, Bullhead City AZ, Las Vegas NV,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Chandler AZ, Tucson AZ, Oceanside CA, El Paso TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Chandler AZ, Tucson AZ, La Jolla CA, Fullerton CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase 3, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Chandler AZ, Gilbert AZ, Mesa AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase 3, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Chandler AZ, Las Vegas NV, Los Alamitos CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase 3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Chandler AZ, Glendale AZ, Goodyear AZ, St. George UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Chandler AZ, Henderson NV, Irvine CA, Duarte CA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase 2, Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
for
Metastatic Colorectal Cancer
Location: Chandler AZ, Los Alamitos CA, Long Beach CA, Calgary,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06252649
Phase 3, Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Chandler AZ, Gilbert AZ, Glendale AZ, Tucson AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase 2, Recruiting
Shield Post-Approval Study Protocol
for
Colo-rectal Cancer
Location: Chandler AZ, Gilbert AZ, Palm Springs CA, Anaheim CA,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 45 - 70+
Code: NCT06880055
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy